Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1358-1365

  Hung, Chih Hsin ^a   Kuo, Chih Feng ^a   Wang, Chiou Huey ^c   Wu, Ching Ming ^b   Tsao, Nina ^a  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BACTERIAL COUNT; BACTERIOLYSIS; BACTERIOPHAGE; BACTERIOPHAGE THETA NK5; BLOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL THERAPY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LIVER; LIVER ABSCESS; LIVER NECROSIS; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTEREMIA; BACTERIOPHAGES; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIVER ABSCESS; MICE; MICE, INBRED C57BL;

EID: 79953189046     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01123-10     Document Type: Article

References (46)

1. Ahmad, S. I. 2002. Treatment of post-burns bacterial infections by bacteriophages, specially ubiquitous Pseudomonas spp. notoriously resistant to antibiotics. Med. Hypotheses 58:327-331. (Pubitemid 34774831)
2. Arakawa, Y., et al. 1991. Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2). Infect. Immun. 59:2043-2050.
3. Arakawa, Y., et al. 1995. Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J. Bacteriol. 177:1788-1796.
4. Biswas, B., et al. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
5. Bruttin, A., and H. Brüssow. 2005. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49:2874-2878.
6. Büchen-Osmond, C. (ed). 2006. ICTVdB management. In ICTVdB - the Universal Virus Database, version 4. Columbia University, New York, NY.
7. Cahill, M., B. Chang, and A. Murray. 2000. Bilateral endogenous bacterial endophthalmitis associated with pyogenic hepatic abscess. Br. J. Ophthalmol. 84:1436.
8. Cairns, B. J., and R. J. H. Payne. 2008. Bacteriophage therapy and the mutant selection window. Antimicrob. Agents Chemother. 52:4344-4350.
9. Capparelli, R., M. Parlato, G. Borriello, P. Salvatore, and D. Iannelli. 2007. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother. 51:2765-2773.
10. Chang, S. C., C. T. Fang, P. R. Hsueh, Y. C. Chen, and K. T. Luh. 2000. Klebsiella pneumoniae isolates causing liver abscess in Taiwan. Diagn. Microbiol. Infect. Dis. 37:279-284.
11. Chhibber, S., S. Kaur, and S. Kumari. 2008. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J. Med. Microbiol. 57:1508-1513.
12. Chibani-Chennoufi, S., et al. 2004. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob. Agents Chemother. 48:2558-2569.
13. Chiu, C. H., L. H. Su, T. L. Wu, and I. J. Hung. 2001. Liver abscess caused by Klebsiella pneumoniae in siblings. J. Clin. Microbiol. 39:2351-2353.
14. Chuang, Y. P., C. T. Fang, S. Y. Lai, S. C. Chang, and J. T. Wang. 2006. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J. Infect. Dis. 193:645-654.
15. Cortés, G., B. de Astorza, V. J. Benedi, and S. Alberti. 2002. Role of the htrA gene in Klebsiella pneumoniae virulence. Infect. Immun. 70:4772-4776.
16. Fang, C. T., Y. C. Chen, S. C. Chang, W. Y. Shau, and K. T. Luh. 2000. Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM 93:45-53.
17. Fang, C. T., Y. P. Chuang, C. T. Shun, S. C. Chang, and J. T. Wang. 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 199:697-705.
18. Fortuna, W., R. Miedzybrodzki, B. Weber-Dabrowska, and A. Górski. 2008. Bacteriophage therapy in children: facts and prospects. Med. Sci. Monit. 14:RA126-RA132.
19. Fung, C. P., et al. 2002. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50:420-424.
20. Gutiérrez, D., B. Martínez, A. Rodríguez, and P. García. 2010. Isolation and characterization of bacteriophages infecting Staphylococcus epidermidis. Curr. Microbiol. 61:601-608.
21. Hagens, S., A. Habel, U. von Ahsen, A. von Gabain, and U. Bläsi. 2004. Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob. Agents Chemother. 48:3817-3822.
22. Huang, C., Y. Zhang, and N. Jiao. 2010. Phage resistance of a marine bacterium, Roseobacter denitrificans OCh114, as revealed by comparative proteomics. Curr. Microbiol. 61:141-147.
23. Hughes, K. A., I. W. Sutherland, J. Clark, and M. V. Jones. 1998. Bacteriophage and associated polysaccharide depolymerases - novel tools for study of bacterial biofilms. J. Appl. Microbiol. 85:583-590.
24. Jensen, E. C., et al. 1998. Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa. Appl. Environ. Microbiol. 64:575-580.
25. Ko, W. C., et al. 2002. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg. Infect. Dis. 8:160-166.
26. Kumari, S., K. Harjai, and S. Chhibber. 2009. Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. J. Microbiol. Biotechnol. 19:622-628.
27. Kuo, C. F., Y. H. Wang, H. Y. Lei, C. H. Wang, and N. Tsao. 2007. Concanavalin A protects mice from a lethal inoculation of intragastric Klebsiella pneumoniae and reduces the induced liver damage. Antimicrob. Agents Chemother. 51:3122-3130.
28. Lai, Y. C., S. L. Yang, H. L. Peng, and H. Y. Chang. 2000. Identification of genes present specifically in a virulent strain of Klebsiella pneumoniae. Infect. Immun. 68:7149-7151.
29. Langley, R., D. T. Kenna, P. Vandamme, R. Ure, and J. R. Govan. 2003. Lysogeny and bacteriophage host range within the Burkholderia cepacia complex. J. Med. Microbiol. 52:483-490.
30. Lau, Y. J., et al. 2000. Identification of a major cluster of Klebsiella pneumoniae isolates from patients with liver abscess in Taiwan. J. Clin. Microbiol. 38:412-414.
31. Lederman, E. R., and N. F. Crum. 2005. Pyrogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am. J. Gastroenterol. 100:322-331.
32. Lin, J. C., L. K. Siu, C. P. Fung, K. M. Yeh, and F. Y. Chang. 2007. Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. J. Clin. Microbiol. 45:266-269.
33. McVay, C. S., M. Velásquez, and J. A. Fralick. 2007. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob. Agents Chemother. 51:1934-1938.
34. Merino, S., et al. 2000. Cloning and sequencing of the Klebsiella pneumoniae O5 wb gene cluster and its role in pathogenesis. Infect. Immun. 68:2435-2440.
35. Ohmori, S., et al. 2002. Septic endophthalmitis and meningitis associated with Klebsiella pneumoniae liver abscess. Hepatol. Res. 22:307-312.
36. Podschun, R., and U. Ullmann. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11:589-603.
37. Reyrolle, J., M. C. Chopin, F. Letellier, and G. Novel. 1982. Lysogenic strains of lactic acid streptococci and lytic spectra of their temperate bacteriophages. Appl. Environ. Microbiol. 43:349-356.
38. Sulakvelidze, A., Z. Alavidze, and J. G. Morris, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
39. Tsao, N., C. F. Kuo, H. Y. Lei, S. L. Lu, and K. J. Huang. 2010. Inhibition of group A streptococcal infection by Melaleuca alternifolia (tea tree) oil concentrate in the murine model. J. Appl. Microbiol. 108:936-944.
40. Wang, J. H., et al. 1998. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin. Infect. Dis. 26:1434-1438.
41. Wang, J., et al. 2006. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int. J. Mol. Med. 17:309-317.
42. Watanabe, R., et al. 2007. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents Chemother. 51:446-452.
43. Weber-Dabrowska, B., M. Mulczyk, and A. Górski. 2000. Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch. Immunol. Ther. Exp. 48:547-551.
44. Weiss, B. D., M. A. Capage, M. Kessel, and S. A. Benson. 1994. Isolation and characterization of a generalized transducing phage for Xanthomonas campestris pv. campestris. J. Bacteriol. 176:3354-3359.
45. Wills, Q. F., C. Kerrigan, and J. S. Soothill. 2005. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob. Agents Chemother. 49:1220-1221.
46. Wu, K. M., et al. 2009. Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J. Bacteriol. 191:4492-4501.